Maidstone
. Scoring system used in the assessment of the six key primary symptoms and signs of inflammation The six key primary symptoms and signs of inflam mation were defined as: (I) burning/itching, (2) ocular pain, (3) corneal oedema, (4) conjunctival hyperaemia, (5) anterior chamber flare, (6) anterior chamber cellular activ ity. Each patient was seen by one of four doctors (l.S., e.L., 1.A.B., e.G.F.M.) on each visit: in an attempt to stan dardise the results the symptoms and signs were given a score from 0 to 3 based on the severity of the findings as classified in Table I .
Instruments such as the Kowa laser flare and cell meter have recently been developed and allow a more objective measurement of anterior chamber activity.7� It was felt, however, that differences between the two topical prep arations detectable only with the flare and cell meter would not be clinically significant. The method of clinical assessment used was therefore based on that described by Hogan and co-workers.9 The cellular activity was deter mined from the number of cells seen in a standard oblique slit beam (3 mm long and 1 mm wide) whilst the flare was assessed by comparing the density of the flare with that showed on a graded standard chart.
The secondary signs were defined as ciliary hyper aemia, conjunctival discharge and the presence of iris syn echiae (in the undilated resting state): they were also assessed on each examination. They were judged to be either absent or present and given a score of 0 or 2 accordingly.
To lerance to the treatment was also assessed on each Ill. I I
RESULTS
Eighty patients were enrolled on the study of whom 2 were excluded from the safety analysis due to violation of the exclusion criteria. Seventy-eight patients were therefore assessed for drug safety and tolerance. Eight patients were excluded during stage I of the trial: 4 of these were excluded due to peri-operative changes in the surgical pro tocol, I patient died due to a cerebrovascular accident post-operatively, 2 were lost to follow-up and I was dis covered to have suffered from chronic simple glaucoma. A further 3 patients were excluded from stage 2 of the trial: 2 were lost to follow-up and I in the Betnesol-N group
Mean Score The results for local tolerance showed that during the study there was a steady decrease. similar in both groups, in the number of patients complaining of burning or itch ing after application of the drops.
There was also no difference in the overall tolerance of There was I case of adverse drug effect clinically felt to be neomycin allergy and there were no problems in the non-operated fellow eyes assessed during the study.
DISCUSSION
The mechanism of action of diclofenac and other non This study suggests that diclofenac sodium-gentamicin appears to be an acceptable alternative to conventional steroid/antibiotic preparations after catataract surgery.
Whilst the general trend recently has been towards shorter post-operative courses of anti-inflammatories we feel that diclofenac sodium is a useful addition as another anti inflammatory agent and has a particular use in patients with a previous history of recurrent herpetic infection or steroid-responsive glaucoma. 
